You are here

Abivax

After a record run, fewer biotechs are going public. Here’s how they’re performing.

BioPharma Dive

Tue, 12/19/23 - 11:42 am

Cargo Therapeutics

Lexeo Therapeutics

Neumora Therapeutics

Lexeo, Abivax File for IPOs on Nasdaq Amid Industry-Wide Drought

BioSpace

Mon, 10/2/23 - 10:40 am

Lexeo Therapeutics

genetic medicine

The big Covid-19 trials still to report

EP Vantage

Wed, 02/17/21 - 10:48 am

clinical trials

Abivax Bolstered by Positive Mid-Stage Results from Ulcerative Colitis Treatment

BioSpace

Tue, 09/4/18 - 11:22 pm

ulcerative colitis

Positive momentum for French biotech industry continues: Abivax announces positive Phase II results (HIV)

GoinPharma

Mon, 07/9/18 - 10:56 am

Abivax up on mixed HIV data

Biopharma Dive

Wed, 07/4/18 - 10:02 am

Abivax May List on Nasdaq After U.S. Lifts Cuba Embargo

Bloomberg

Thu, 07/2/15 - 11:22 am

Abivax tees up a $49M IPO to get its hep B shot into Phase III

Fierce Biotech

Fri, 06/5/15 - 10:38 am